PolyPid (PYPD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PYPD PolyPid

Watchlist

3.5900
+0.4400+13.97%

Close Sep 12 16:00 ET

24.42MMarket Cap-142P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

PolyPid to Participate in Three Upcoming Fall Investor Conferences
Yahoo FinanceSep 3 07:00 ET
PolyPid Files for Potential Sale of 3.9 Million Shares
MT NewswiresAug 30 17:03 ET
Express News | PolyPid Ltd Files for Resale of up to 3.9 Mln Ordinary Shares by the Selling Shareholders - SEC Filing
ReutersAug 30 16:03 ET
Barclays Maintains PolyPid(PYPD.US) With Hold Rating, Maintains Target Price $10
Moomoo NewsAug 19 08:33 ET · Ratings
PolyPid (PYPD) Receives a Hold From Barclays
TipRanksAug 19 08:18 ET · Ratings
PolyPid Analyst Ratings
BenzingaAug 15 06:48 ET · Ratings

Comments

Trytosaveabit

Jun 18 06:21

Make a note!

$PolyPid (PYPD.US)$ Approximately 250 Patients of a Planned Total of 600 Subjects Currently Enrolled in SHIELD II
Unblinded Interim Analysis to be Conducted Once Approximately 400 PatientsComplete Their 30-Day Follow-up; Top-line Results Expected in the First Quarter of 2025

Jaguar8

Apr 30 06:02

$PolyPid (PYPD.US)$
NEWS
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections

Trytosaveabit

Oct 17, 2023 17:22

$PolyPid (PYPD.US)$ Amazing what such a small buy can do? LMAO

Trytosaveabit

Oct 17, 2023 17:21

$PolyPid (PYPD.US)$ NICE

Trytosaveabit

Oct 11, 2023 06:06

Update

$PolyPid (PYPD.US)$ Regained compliance

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data